Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,546.27 157.50 1.09%
TOPIX 1,173.81 11.31 0.97%
HANG SENG 22,509.64 -221.04 -0.97%

Cannabis Biotech Initiates Development of Cannabis Infused Beverages



  Cannabis Biotech Initiates Development of Cannabis Infused Beverages

Company to expand product line with medical marijuana beverages

Business Wire

FT. LAUDERDALE, Fla. -- October 30, 2013

Puget Technologies (OTCBB:PUGE) announced its subsidiary, Cannabis Biotech, is
initiating the development of a cannabis infused beverage line. The beverages
will be developed using flavor profiles and active ingredients based on the
company’s ongoing research.

This effort is part of Cannabis Biotech’s investigation of alternative
delivery systems for medical marijuana to appeal to the growing number of
patients who desire the benefits of medical marijuana but do not want the
harmful effects or stigma of smoking it. This is in response to the shift in
thinking in the U.S. where 20 states and the District of Columbia have now
enacted laws legalizing the use of medical marijuana.

Forbes reported the U.S. medical marijuana market, worth $1.7 billion in 2011,
will explode to $9 billion by 2016.

President and CEO of Puget Technologies Ron Leyland said, “Our outstanding
research and development team is pushing the limits to achieve superior
delivery methods for the growing market seeking natural cannabis-based
medicine.” He added, “Cannabis BioTech is committed to becoming an industry
research leader as it develops products using rigorous protocols, strict
administration and exacting quality standards.”

Earlier this year, Puget Technologies, led by Leyland, entered the $40 billion
energy drink market with a line of energy drinks and shots. Leyland said the
cannabis-infused beverages will provide a refreshing, organic alternative for
patients seeking relief from nausea, chronic pain, muscle spasms and other
conditions.

In addition to the beverages, Cannabis Biotech is also exploring sophisticated
transmucosal delivery systems (administered through the mucous membranes) and
transdermal patches to add to its growing product line.

Cannabis Biotech is entering a market including industry frontrunners such as
Coca-Cola Company (NYSE: KO), Anheuser-Busch InBev (NYSE: Bud) and Molson
Coors Brewing Company (NYSE:TAP).

More information about Cannabis BioTech can be found at
http://www.cannabisbiotech.com.

About Puget Technologies (PUGE)

Puget Technologies is a publicly traded company on the OTCBB Market stock
exchange under the ticker symbol PUGE. Headquartered in Ft. Lauderdale,
Florida, Puget Technologies acquires, develops and sells leading edge consumer
oriented products ready for rapid commercialization. Product lines under
development include B-29 Energy Drinks and several medical marijuana products
through its subsidiary, Cannabis Biotech. Puget’s strategy is to become a
recognized market leader in its product categories. Much of its resources are
dedicated to research and development in order to provide consumers with
quality options while meeting the expectations of its investors.

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipates," or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release only speaks as of the date of its
distribution.

Contact:

Puget Technologies
Ron Leyland, 954-332-2471
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement